drug
(acetaminophen + ibuprofen sodium)
Marketedupdated 3mo agoby Hikma Pharmaceuticals USA Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugIBUPROFEN1 co-mentions · 1 sources
- companyAjou University Hospital1 co-mentions · 1 sources
- tagPain1 co-mentions · 1 sources
- drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN1 co-mentions · 1 sources
- drugOXYCODONE HYDROCHLORIDE AND IBUPROFEN1 co-mentions · 1 sources
- drug(acetaminophen + ibuprofen)1 co-mentions · 1 sources
- drugMidol1 co-mentions · 1 sources
- drugAdvil1 co-mentions · 1 sources
all catalysts(1)
Trials studying (acetaminophen + ibuprofen sodium)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 27, 2039
~12.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Feb 27, 2039formulationUS 11197830
- Feb 27, 2039formulationUS 11534407
FDA exclusivities (1)
- Mar 1, 2026NPNP
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 20m ago
Found something off?
comments(0)
5-min edit window · permanent after that